Greenwich LifeSciences GLSI 深 沪
等待开盘 08-06 09:30:00 美东时间
11.6874
-0.253
-2.12%
华盛通- 最 高12.00
- 今 开12.00
- 成交量 9568股
- 最 低 11.59
- 昨 收 11.94
- 总市值 1.56亿
- 52周最高 16.50
- 市盈率 静 --
- 换手率 0.07%
- 52周最低 8.06
- 委 比 73.91%
- 总股本 1336.83万
- 历史最高 158.07
- 量 比 0.43
- 振 幅 3.43%
- 历史最低 3.262
- 每 手 1
- 风险率 2.78%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Greenwich LifeSciences Q1 EPS $(0.25) Down From $(0.19) YoY
Greenwich LifeSciences (NASDAQ:GLSI) reported quarterly losses of $(0.25) per share. This is a 31.58 percent decrease over losses of $(0.19) per share from the same period last year.
05-21 05:58
美股大行评级 | 潜在涨幅3020.12%！Ascendiant Capital上调Plus Therapeutics目标价至20美元，维持"买入"评级
每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。
04-22 08:41
Greenwich LifeSciences Announced An Update On FLAMINGO-01 Open Label Safety Data
FLAMINGO-01 Data Safety Monitoring Board (DSMB)The FLAMINGO-01 DSMB met twice in 2024, most recently in December 2024, and recommended to continue the study as is without modification. No serious adverse events related
03-17 18:47
美股大行评级 | 潜在涨幅119%！Compass医疗获杰富瑞升目标价至8美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1096354625327304705.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Jones Trading：上调In8bio(INAB)评级至"买入"，目标价1.2美元</p> <p>• 丰业银行：维持INmune Bio(INMB)"跑赢大市"评级，目标价从22美元升至23美元</p> <p>•
02-12 09:54
Greenwich LifeSciences Reports Initiation Of New Clinical Sites In US
Both Harvard University and Johns Hopkins University sites were recently added as participating sites in FLAMINGO-01 in the US and both principal investigators, Laura Spring and Cesar Santa-Maria have joined the Steering
01-23 19:09
Greenwich LifeSciences gains after GP2 commercial manufacturing update
Greenwich LifeSciences (NASDAQ:GLSI) traded higher on Wednesday after the immunotherapy developer updated on the commercial manufacturing of its lead candidate GP2, which is currently undergoing a lat...
01-23 04:07
Greenwich Lifesciences Inks Partnership With GBG In Germany For Flamingo-01
The Company has partnered with GBG (German Breast Group), the largest academic breast cancer research network in Germany, where approximately 38 sites have agreed to participate in FLAMINGO-01. Most of the sites have
01-14 19:19
Greenwich LifeSciences joins hands with GIM in Italy
Clinical-stage biopharmaceutical Greenwich LifeSciences (NASDAQ:GLSI) announced its partnership with clinical sites in Italy. "Italy is the first country where we have personally visited and trained a...
2024-11-26 19:20
Greenwich LifeSciences files for $275M mixed securities shelf
Greenwich LifeSciences (NASDAQ:GLSI) filed for $275M mixed securities shelf. This prospectus is not an offer to sell. Filing More on Greenwich Lifesciences Seeking Alpha’s Quant Rating on Greenwich Li...
2024-10-08 05:13
Greenwich LifeSciences to join Russell 2000 index
Greenwich LifeSciences (NASDAQ:GLSI) said it is set to join the Russell 2000 and Russell 3000 Indexes at the conclusion of the Russell indexes annual reconstitution. Press Release More on Greenwich Li...
2024-06-26 19:43
